News and Trends 5 Dec 2022
Kintor Pharma says alopecia primary endpoint met
Kintor Pharmaceutical Limited has announced results of a phase II clinical trial of pyrilutamide (KX-826), a potential first-in-class topical drug, for the treatment of adult female androgeneticalopecia (AGA). The company…